Nicofuranose
Nicofuranose
|
Systematic (IUPAC) name |
---|
1,3,4,6-tetrakis-O-(pyridin-3-ylcarbonyl)-β-D-fructofuranose |
Clinical data |
---|
Identifiers |
---|
|
C10AD03 |
---|
PubChem |
CID 25495 |
---|
ChemSpider |
23791 N |
---|
UNII |
GF99P6327K Y |
---|
KEGG |
D07189 Y |
---|
Chemical data |
---|
Formula |
C30H24N4O10 |
---|
|
600.533 g/mol |
---|
SMILES
- C1=CC(=CN=C1)C(=O)OC[C@@H]2[C@H]([C@@H]([C@](O2)(COC(=O)C3=CN=CC=C3)O)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5
|
InChI=1S/C30H24N4O10/c35-26(19-5-1-9-31-13-19)40-17-23-24(42-28(37)21-7-3-11-33-15-21)25(43-29(38)22-8-4-12-34-16-22)30(39,44-23)18-41-27(36)20-6-2-10-32-14-20/h1-16,23-25,39H,17-18H2/t23-,24-,25+,30-/m1/s1
N
Key:FUWFSXZKBMCSKF-ZASNTINBSA-N
N
|
N (what is this?) (verify) |
---|
Nicofuranose is a niacin derivative used as a hypolipidemic agent.
|
---|
| GI tract | |
---|
| Liver | | |
---|
| Niacin and derivatives ( HDL and LDL) | |
---|
| | |
---|
|
---|
| Blood vessels | |
---|
| Combinations | |
---|
| Other | |
---|
| | | |
---|
| Description |
- Vitamins
- Cofactors
- Metal metabolism
- Fats
- metabolism
- intermediates
- lipoproteins
- Sugars
- Glycolysis
- Glycogenesis and glycogenolysis
- Fructose and galactose
|
---|
| Disease |
- Vitamins
- Carbohydrate
- Lipid
- Metals
- Other
- Symptoms and signs
|
---|
| Treatment |
- Drugs
- Vitamins
- Mineral supplements
|
---|
|
|